OBSERVATIONAL STUDY TO ASSESS ROLE OF AHARAA IN THE GENESIS OF HRIDROG (IHD)
Keywords:
Aharaj nidan, Hridrog, Nidan parivarjanAbstract
Hridrog (ischemic heart disease) is one of the major causes for morbidity and mortality in the entire world. Hridrog (IHD) has become a worldwide health problem in all economical groups of society and is responsible for 13 million of deaths per year in the entire world according to WHO. The mortality due to cardiovascular disease ranges from 15-16% in the developed and developing countries out of which most of deaths occur due to IHD. The Etiological factors of Hridrog according to Ayurveda, describe three categories, Aharaj (dietetic factors), Viharaj (somatic factors) and Manasika (psychological factors). Modern Medicine on the other hand, based on clinical and experimental evidence puts the blame on food containing large amounts of saturated fat, and cholesterol and cigarette smoking and stress and strains of modern sophisticated life. In the presence of above the etiological factors the Doshas get vitiated and get accumulated in Hriday and vitiate Rasa, produce Hridrog. Ayurveda has its own unique and fundamental concepts and principles to prevent and cure the diseases, such as Nidan parivarjana. Aharaj Nidan parivarjana means remove of Aharaj hetu that genesis the diseases. It is fundamental and fist line treatment to treat the diseases in which strict Aharaj plan to be followed according to nidan (causes of disease), prakruti, ritu (season), desh (place), kala (time) to cure the diseases. The positive solutions can be obtained and achieved by the Principal of Ayurveda hence in this present study 60 patients of IHD to observe the Aharaj nidan by Aharaj questionnaire “Observational Study to Assess Role of Ahara in the Genesis of Hridrog (IHD)” is a humble effort in this direction.
Downloads
Published
How to Cite
Issue
Section
Copyright (c) 2024 Pankaj Masodker, Priyanka Mhaske, Vyas Antim, Pawar Shivaji

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
